Stem-cell driven cancer: "hands-off" regulation of cancer development

Carolina Vicente-Dueñas1, María Pérez-Caro, Fernando Abollo-Jiménez

  • 1Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Campus M. Unamuno s/n, Salamanca, Spain.

Insights

Cancer oncogenes may not need continuous expression to drive tumor growth. A study shows oncogene inactivation can lead to remission, challenging the "hands-on" cancer model and suggesting new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • The traditional cancer model posits that oncogenes are essential throughout tumor development.
  • This
  • hands-on
  • model assumes continuous oncogene activity is required for cancer maintenance.
  • All cancer cells typically share the same oncogenic genetic lesions.

Purpose of the Study:

  • To investigate the role of oncogene expression in cancer development using a mouse model.
  • To challenge the established
  • hands-on
  • cancer model.
  • To explore the potential of targeting cancer stem cells (CSCs) and the
  • hands-off
  • function of oncogenes.

Main Methods:

  • Utilized a mouse model with restricted oncogene expression to the stem cell compartment.
  • Focused on the BCR-ABL oncogene, linked to chronic myeloid leukemia (CML).
  • Investigated the impact of limiting oncogene expression to Sca1(+) cells.

Main Results:

  • Demonstrated that chronic myeloid leukemia (CML) arises even when BCR-ABL oncogene expression is restricted to stem cells.
  • Indicated that sustained oncogene expression is not essential for generating differentiated tumor cells.
  • Revealed a potential
  • hands-off
  • role for BCR-ABL in cancer formation.

Conclusions:

  • The study challenges the conventional
  • hands-on
  • model of cancer, suggesting oncogenes may have a
  • hands-off
  • function.
  • This finding has implications for understanding cancer development and therapeutic strategies.
  • Highlights the potential for targeting cancer stem cells (CSCs) and the dynamic nature of oncogene dependence.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...